Experienced in Myeloproliferative Neoplasms (MPN)

Gaelle Vertenoeil

Brussels Branch, 
Brussels, BRU, BE 
Experienced in Myeloproliferative Neoplasms (MPN)
Brussels Branch, 
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Gaelle Vertenoeil practices in Brussels, Belgium. Ms. Vertenoeil is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Essential Thrombocythemia, Yellow Nail Syndrome, Polycythemia Vera, and Myelofibrosis.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Myeloproliferative Neoplasms (MPN).

Gender
Female

Locations

Brussels Branch, Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients
A Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: CPI-0610 BET Small Molecule Inhibitor, Ruxolitinib
Study Phase: Phase 3

16 Total Publications

Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025.
Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vertenoeil's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile